Pfizer Inc



    Today's change

    0.20 / +0.67%

    1 year change


    As of Apr 16 2014 21:00 BST. Data delayed by at least 15 minutes.

Search for Pfizer Inc and
  1. NEW


    UK cancer charity and companies test new style of drug trial

    A partnership between drug companies and the charity Cancer Research UK is pioneering an approach to clinical development,...

  2. April 8, 2014

    Doubts emerge about ‘wonder drugs’

    Takeda’s Actos – generic name pioglitazone – belongs to a class of three drugs called glitazones, which were acclaimed on...

Special Reports

  1. Combating Tuberculosis

    The emergence of deadly new drug-resistant strains of TB threatens to unravel years of...
  2. Doing Business in Wallonia

    Wallonia, the French-speaking region of Belgium, is rethinking an economy traditionall...
Search more Special Reports on this topic.

  1. April 7, 2014

    Pfizer falls as treatment trial disappoints

    Pfizer, the US pharmaceuticals group, weakened on Monday after results of a mid-stage experimental breast cancer treatment...

  2. March 24, 2014

    Linezolid, a potential new TB cure, is trapped in a Catch-22

    It is expensive, inaccessible, poorly tested and potentially toxic with side effects including intense pain. But linezolid...

  3. March 20, 2014

    US companies urge restraint on Russia sanctions

    President Barack Obama’s move to expand sanctions punishing Russia could raise fears in corporate America of an extended...

  4. March 17, 2014

    Viagra scientist chases new sexual health breakthrough

    One of the scientists behind Viagra is chasing a fresh breakthrough in sexual health as his company closes in on a deal for...

  5. March 14, 2014

    Fast-track plan for serious illness medicines

    Drug companies have welcomed a move to accelerate the introduction of medicines for seriously ill patients as part of...

  6. February 20, 2014

    SEC claims drunk lawyer had insider tipple

    An alleged insider trading scheme involving a claim about an intoxicated lawyer and his wealth manager has drawn the...

  7. February 3, 2014

    Pfizer bucks declines on cancer drug trial hopes

    Shares in US pharmaceuticals group Pfizer rallied on Monday after a mid-stage drug trial of an experimental breast cancer...

  8. January 28, 2014

    Pfizer sales decline on increased competition from generics

    Pfizer reported better than expected fourth-quarter profit on Tuesday, but revenues fell as the maker of Lipitor and Viagra...

  9. January 28, 2014

    Chipmakers hit by ebbing iPhone sales growth

    US chipmakers suffered from concerns about a slowing in the rate of growth of smartphone sales, following weaker than...

  10. January 19, 2014

    Local expertise leads revival

    While most saw Pfizer’s Sandwich closure as a serious setback for the region and the UK economy, Simon Westbrook regarded it...

  11. January 19, 2014

    Kent research site survives ‘Armageddon’

    It was described as “Armageddon” for those affected and a “body blow” for the economy of east Kent. When Pfizer, the US...

  12. January 10, 2014

    The Doctor: Big pharma and the gift of giving

    At least we know the drug companies love us: they’re always giving us stuff. It starts at medical school. Before you can...

  13. December 26, 2013

    Ethics: End of the hard sell?

    When Johnson & Johnson wanted to boost prescriptions of Natrecor, a heart medicine, it channelled more than $100,000 through...

  14. December 26, 2013

    Drug groups pin hopes on Iran market potential

    When Pfizer sold a small batch of medicines to Iran last year, the process was painful. The pharmaceutical group needed...

  15. FT Alphaville

    December 12, 2013

    Have you noticed? Equities are the new bonds

    We’ve infiltrated Citi’s European Credit Conference, underway in Westminster on Thursday. Updates follow, until we’re thrown...

  16. FT Alphaville

    November 25, 2013

    The 6am London Cut

    Markets: A further slide in the yen is giving a boost to Japanese equities, while commodity prices tumbled after Iran...

  17. November 19, 2013

    Big drugmakers such as Novartis turn from expansion to divestment

    When Novartis revealed the sale of its blood diagnostics business last week, investment bankers could lick their lips at the...

  18. FT Alphaville

    November 5, 2013

    Spot the industry plagued by wrongdoing and huge fines

    No, not everybody’s favourite inside trading hedge fund. The fine that really made us gasp this week was the $2.2bn penalty...

  19. October 29, 2013

    Pfizer to publish separate results for its 3 business units

    Pfizer confirmed it is to separately publish the financial results of its three business divisions from the first quarter of...

  20. October 23, 2013

    Innovation is not all about being creative

    Matt Kingdon is keen not to appear “wacky”. It is something the innovation consultancy director and author of business book,...

  21. September 30, 2013

    Europe belt tightening will hit pharma, warns Roche chief

    Europe risks squandering its leading position in the global pharmaceuticals industry because of the “short-term” and...

  22. FT Data

    September 24, 2013

    China's pharmaceutical market: risks and opportunities

    The media furore surrounding Beijing’s probes into corruption by drug companies has drawn attention to the nature of China’s...

  23. September 22, 2013

    Pioneer medical fund takes in $94m

    A pioneering socially orientated private equity fund to finance medical products for the world’s poor has raised $94m from...

  24. August 30, 2013

    Small-cap week, August 31

    Petropavlovsk was among the sharpest small-cap fallers this week after record production from the Russian gold miner failed...

  25. August 18, 2013

    Drug company contributions can ‘influence’ medical decisions

    Doctors in the US who are paid and entertained by drug companies are more than twice as likely to prescribe their products,...

  26. August 13, 2013

    GSK subsidiary wins watchdog approval for HIV treatment

    GlaxoSmithKline stands to receive a substantial financial boost after US regulatory approval of a new HIV treatment produced...

  27. July 30, 2013

    Pfizer finalises overselling settlement

    Pfizer has finalised a criminal and civil settlement worth $491m with US authorities for alleged overselling of a transplant...

  28. FT Alphaville

    July 30, 2013

    The Closer

    FURTHER FURTHER READING - What’s an idea worth? - Keep insider trading illegal. - Obama has set a poor test for choosing a...

  29. July 30, 2013

    Pharma gives US stocks a boost

    Pharmaceutical blue-chips Pfizer and Merck highlighted the mixed earnings season, as the S&P 500 continued its recent run of...

  30. July 30, 2013

    Pfizer earnings hit by sales drop

    Pfizer reported earnings a share down 5 per cent in the second quarter on sales down 7 per cent following patent...

  31. July 28, 2013

    Ireland’s ‘patent cliff’ poses problems for exit of bailout

    The metal reactors at Pfizer’s 200-acre manufacturing plant in Ringaskiddy that make the drug Viagra are not as busy as they...

  32. July 24, 2013

    China’s claims against GlaxoSmithKline echo SEC actions

    The allegations that Chinese authorities have made against GlaxoSmithKline’s operations resemble those levelled at other...

  33. July 22, 2013

    Big Pharma in China: getting tougher

    China’s war on corruption is overdue. Its allegations of bribery against GlaxoSmithKline are evidence that it is serious –...

  34. July 18, 2013

    Belgian pharma group in China probe

    UCB has become the latest focus of inquiries by Chinese officials in a growing clampdown on drug pricing and marketing...

  35. July 15, 2013

    GSK is test case in China’s rules laboratory

    Hundreds of millions of dollars of allegedly improper payments under review by the Chinese police. Evidence of sexual...

  36. June 27, 2013

    Pfizer unveils $10bn share buyback

    Pfizer on Thursday announced a $10bn share buyback, bringing the total for its stock repurchase programme over the past...

  37. June 27, 2013

    Drugs groups face credit rating threat as population ages

    Credit ratings of the world’s largest pharmaceutical groups are set to suffer as governments try to control the cost of...

  38. June 25, 2013

    Eisai to pull epilepsy drug from Germany

    Eisai, the Japanese pharmaceutical group, is to stop selling its new epilepsy drug in Germany over concerns that the...

Search for Pfizer Inc and